Lina Liu
Impact in
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Molecular Biology top 10%
- RNA modifications and cancer
- Circular RNAs in diseases
- Cancer-related gene regulation
Papers in
-
- RNA modifications and cancer 10
- Circular RNAs in diseases 4
-
- Cancer-related molecular mechanisms research 9
- MicroRNA in disease regulation 3
- Co-authors
- Jie Wu (6 shared papers)Jingwen Liu (5 shared papers)Shiqing Ma (4 shared papers)Xiaoqian Qi (3 shared papers)Wei Zhao (5 shared papers)Qi Liu (1 shared paper)Lei Miao (1 shared paper)Jun Li (1 shared paper)
- Journals
- Molecular Therapy — Nucleic Acids (3 papers)Biomedicine & Pharmacotherapy (2 papers)Biomedical Optics Express (2 papers)Clinica Chimica Acta (1 paper)Journal of Cellular Biochemistry (1 paper)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Lina Liu
31 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 96
- Cancer Research 660
- Molecular Biology 1.1k
- Immunology 330
- Oncology 329
- Biomaterials 105
Countries citing papers authored by Lina Liu
This map shows the geographic impact of Lina Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lina Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lina Liu more than expected).
Fields of papers citing papers by Lina Liu
This network shows the impact of papers produced by Lina Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lina Liu. The network helps show where Lina Liu may publish in the future.
Co-authors
The 25 scholars most cited alongside Lina Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 294 | |
| 2 | 2016 | 189 | |
| 3 | 2019 | 189 | |
| 4 | 2019 | 168 | |
| 5 | 2020 | 146 | |
| 6 | 2018 | 82 | |
| 7 | 2019 | 57 | |
| 8 | 2018 | 50 | |
| 9 | 2022 | 48 | |
| 10 | 2015 | 46 | |
| 11 | 2019 | 39 | |
| 12 | 2019 | 36 | |
| 13 | 2022 | 33 | |
| 14 | 2019 | 27 | |
| 15 | 2019 | 27 | |
| 16 | 2018 | 22 | |
| 17 | 2021 | 21 | |
| 18 | 2023 | 19 | |
| 19 | 2023 | 14 | |
| 20 | 2019 | 12 |
About Lina Liu
Lina Liu is a scholar working on Molecular Biology, Cancer Research, Immunology, Pulmonary and Respiratory Medicine and Oncology, having authored 34 papers that have together received 1.6k indexed citations. Recurring topics across this work include RNA modifications and cancer (10 papers), Cancer-related molecular mechanisms research (9 papers), Circular RNAs in diseases (4 papers), Immunotherapy and Immune Responses (3 papers), Immune cells in cancer (3 papers), MicroRNA in disease regulation (3 papers), Advanced Fluorescence Microscopy Techniques (3 papers) and Cell Image Analysis Techniques (2 papers). The work is most often cited by research in Cancer Research (660 citations), Molecular Biology (1.1k citations), Immunology (330 citations), Oncology (329 citations) and Biomaterials (105 citations). Lina Liu has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Jie Wu, Jingwen Liu, Shiqing Ma, Xiaoqian Qi, Wei Zhao, Qi Liu, Lei Miao, Jun Li, Sara Musetti and Yuhua Wang. Their work appears in journals such as Molecular Therapy — Nucleic Acids, Biomedicine & Pharmacotherapy, Biomedical Optics Express, Clinica Chimica Acta and Journal of Cellular Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.